Cite
HARVARD Citation
Lythgoe, M. et al. (n.d.). 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. Journal for immunotherapy of cancer. pp. A481-A482. [Online].